%0 Journal Article
%K Humans
%K *Diabetes Mellitus, Type 2/epidemiology/drug therapy
%K *Electronic Health Records/statistics & numerical data
%K Female
%K Male
%K *Machine Learning
%K Middle Aged
%K Prognosis
%K Aged
%K Adult
%K Hypoglycemic Agents/therapeutic use
%K Incidence
%K Follow-Up Studies
%K diabetes mellitus, type 2
%K Electronic Health Records
%K epidemiology
%K Informatics
%K biopharmaceutical company, and declare stock and stock options. AB has received
%K research funding from AstraZeneca. KK has acted as a consultant, speaker or
%K received grants for investigator-initiated studies for AstraZeneca, Bayer,
%K Novartis, Novo Nordisk, Sanofi-Aventis, Lilly and Merck Sharp & Dohme, Boehringer
%K Ingelheim, Oramed Pharmaceuticals, Roche and Applied Therapeutics.
%B BMJ Open Diabetes Res Care
%D 2024
%G eng
%M 38834334
%R 10.1136/bmjdrc-2024-004191
%T Identifying subtypes of type 2 diabetes mellitus with machine learning: development, internal validation, prognostic validation and medication burden in linked electronic health records in 420 448 individuals
%V 12
%2 PMC11163636
%7 2024/06/05
%@ 2052-4897